Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients

Iranian Journal of Kidney Diseases

Volumn 7, Issue 1, 2013, Pages 47-52

  Khatami, Mohammad Reza ^a   Mirchi, Elham ^b   Khazaeipour, Zahra ^c   Abdollahi, Alireza ^d   Jahanmardi, Afsaneh ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular disease; Hemodialysis; Serum magnesium

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A; C REACTIVE PROTEIN; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD VESSEL CALCIFICATION; BODY MASS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERMAGNESEMIA; HYPOMAGNESEMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; REFERENCE VALUE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; APOPROTEIN(A); BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CALCIUM; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNESIUM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; TRIGLYCERIDES; YOUNG ADULT;

EID: 84872777575     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Collins AJ, Li S, Ma JZ, Herzog C. Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis. 2001;38:S26-9.
2. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;32:s112-9.
3. Kao W H L, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999;159:2151-59.
4. He K, Liu K, Daviglus ML, et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113:1675-82.
5. Gartside P, Glueck C. The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. J Am Coll Nutr. 1995;14:71-9.
6. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1998;136:480-90.
7. Ford ES. Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol. 1999;28:645-51.
8. Maier JAM, Malpuech-Brugere C, Zimowska W, Rayssiguier Y, Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta. 2004;1689:13-21.
9. Navarro JF, Mora C, Jimenez A, Torres A, Macia M, Garcia J. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis. 1999;34:43-8.
10. Kelber J, Slatopolsky E, Delmez JA. Acute effects of different concentrations of dialysate magnesium during high-efficiency dialysis. Am J Kidney Dis. 1994;24:453-60.
11. Navarro-Gonzalez J. Magnesium in dialysis patients: serum levels and clinical implications. Clinical Nephrol. 1998;49:373-8.
12. Nasri H, Kheiri S. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients. Saudi J Kidney Dis Transpl. 2008;19:608-13.
13. Robles NR, Escola JM, Albarran L, Espada R, Cruz A. Correlation of serum magnesium and serum lipid levels in hemodialysis patients. Nephron. 1998;27:644-8.
14. Tzanakis IP, Oreopoulos DG. Beneficial effects of magnesium in chronic renal failure: a foe no longer. Int Urol Nephrol. 2009;41:363-71.
15. Baradaran A, Nasri H. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis. Saudi J Kidney Dis Transpl. 2006;17:344-50.
16. Navarro JF, Mora C, Garcia J. Serum magnesium and parathyroid hormone levels in dialysis patients. Kidney Int. 2000;57:2654.
17. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res. 2007;20:237-44.
18. Katopodis KP, Koliousi EL, Andrikos EK, Pappas MV, Elisaf MS, Siamopoulos KC. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration. Artif Organs. 2003;27:853-7.